Faujul Kabir

Faujul Kabir, PhD, currently serves as a Senior Scientist at Beam Therapeutics since November 2024, following a role as Potency Lead in Analytical Development at Ensoma from July 2023 to November 2024. Prior experience includes positions as Scientist 2 in Analytical Development at GreenLight Biosciences (August 2022 - July 2023) and Postdoctoral Scientist at the Fels Cancer Institute for Personalized Medicine (July 2019 - July 2022). Faujul Kabir began a career in research at the University of Malaya as a Postgraduate Scientist (October 2015 - April 2019) and at Southeast University as an Undergraduate Scientist (January 2011 - June 2012). Educational qualifications include a PhD in Molecular Medicine from the University of Malaya and a Bachelor of Pharmacy from Southeast University.